Drug intelligence / Profile preview

Gamma-butyrolactone

Development stage
Discontinued
Modality
Small Molecules
Administration
Oral
01

Overview

Gamma-butyrolactone (GBL) is a colorless, oily liquid industrial chemical and prodrug that is rapidly converted in the body to gamma-hydroxybutyrate (GHB), a central nervous system depressant. GBL itself is not pharmacologically active but exerts its effects through conversion to GHB by paraoxonase (lactonase) enzymes in the blood. The resulting GHB acts as a neurotransmitter or neuromodulator in the brain and produces dose-dependent depressant effects similar to barbiturates and methaqualone. These include drowsiness, nausea, visual distortion at low doses; unconsciousness, seizures, respiratory depression, coma or death at high doses. Chronic use can lead to addiction. Despite being illegal in many countries due to safety concerns and abuse potential—especially as a recreational drug—GBL has been used illicitly for athletic performance enhancement, sleep aid, sexual performance improvement, stress relief and other purposes[1][2][4][5][8].

Brand names
Reviva
Other names
1,2-Butanolide2,3-dihydro furanone2(3H)-Furanone Dihydro3-Hydroxybutyric Acid Lactone4-Butanolide4-Butyrolactone4-Hydroxybutanoic Acid LactoneAcide 4-Hydroxybutanoïque LactoneButyrolactoneButyrolactone GammaDihydro-2(3H)-FuranoneGamma ButirolactonaGamma Hydroxybutyric Acid LactoneTetrahydro-2-FuranoneTetrahydro2-FuranoneTetrahydro 2-Furanone
02

Targets

GABA-B (Gamma-aminobutyric acid receptor type B)Gamma-hydroxybutyrate receptor

Beyond the preview

Go deeper on Gamma-butyrolactone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-butyrolactone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call